Global Analgesics in the Czech Republic Market Research Report 2021
Acetaminophen experienced
considerable growth as a result of the COVID-19 outbreak, with both adult and
paediatric acetaminophen performing well. Concerns about COVID-19 led to panic
buying in early March and continued stockpiling of certain medicines throughout
the first half of 2020. In contrast, misleading information in the Czech media
about the harmfulness of ibuprofen when treating COVID-19 had a strong negative
influence on demand amongst Czech consumers during the year. Combined
products...
Euromonitor International's
Analgesics in Czech Republic report offers a comprehensive guide to the size
and shape of the market at a national level. It provides the latest retail
sales data 2015-2019, allowing you to identify the sectors driving growth.
Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Systemic
Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes
(historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the
Analgesics market;
* Pinpoint growth sectors and
identify factors driving change;
* Understand the competitive
environment, the market’s major players and leading brands;
* Use five-year forecasts to
assess how the market is predicted to develop.
Euromonitor International has
over 40 years' experience of publishing market research reports, business reference
books and online information systems. With offices in London, Chicago,
Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and
Bangalore and a network of over 800 analysts worldwide, Euromonitor
International has a unique capability to develop reliable information resources
to help drive informed strategic planning.
Table of Contents:
KEY
DATA FINDINGS
2020
IMPACT
Acetaminophen
stands out during COVID-19 pandemic
Slowdown
in rise of pain patches, but creams continue to grow
Players
responding to increased demand due to COVID-19
RECOVERY
AND OPPORTUNITIES
Acetaminophen
set to lead growth in systemic analgesics
Topical
analgesics/anaesthetic to benefit from demand for less invasive solutions
Paediatric
segment expected to see growth for both acetaminophen and ibuprofen
CATEGORY
DATA
Table
1 Sales of Analgesics by Category: Value 2015-2020
Table
2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table
3 NBO Company Shares of Analgesics: % Value 2016-2020
Table
4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table
5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table
6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
EXECUTIVE
SUMMARY
COVID-19
impact on consumer health
COVID-19
country impact
Company
response
Retailing
shift
What
next for consumer health?
ALSO READ: http://www.marketwatch.com/story/global-stretchable-conductive-market-outlook-industry-analysis-and-prospect-2021-2021-03-16
MARKET
INDICATORS
Table
7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table
8 Life Expectancy at Birth 2015-2020
MARKET
DATA
Table
9 Sales of Consumer Health by Category: Value 2015-2020
Table
10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table
11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table
12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table
13 Penetration of Private Label in Consumer Health by Category: % Value
2015-2020
Table
14 Distribution of Consumer Health by Format: % Value 2015-2020
Table
15 Distribution of Consumer Health by Format and Category: % Value 2020
Table
16 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table
17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
... continued
CONTACT DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment